BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Accenture
Deloitte
Fish and Richardson
Healthtrust
Mallinckrodt
McKesson
Moodys
Cipla

Generated: January 23, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,876,248

« Back to Dashboard

Summary for Patent: 4,876,248
Title: Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation
Abstract:The present invention relates to products of the formula ##STR1## where R.sub.1 is H or alkyl, n is an integer from 0 to 10, and R.sub.2 is chosen from amongst H, unsubstituted or substituted alkyl radicals, a ##STR2## group, a substituted or unsubstituted phenyl radical, a ##STR3## group, where X is oxygen or sulfur, or a heterocyclic radical with 5 or 6 members, which may or may not be fused to a benzene ring and R.sub.3 is H or OH. The present invention also relates to a process for the preparation of the products of the formula (I), and to the drugs, having in particular an anti-inflammatory effect, containing a product of formula (I).
Inventor(s): Breliere; Jean C. (Montpellier, FR), Emonds-Alt; Xavier (Montpellier, FR), Garcia; Georges (Saint-Gely-du-Fesc, FR)
Assignee: Sanofi (Paris, FR)
Application Number:07/165,080
Patent Claims: 1. A methylene-diphosphonic acid compound having the formula: ##STR56## in which: R.sub.1 is hydrogen or a straight or branched lower alkyl group having from 1 to 4 carbon atoms,

R.sub.2 is a phenyl group which is or substituted one or more times by halogen, a nitro group, a lower alkyl group, a lower alkoxy group, trifluoromethyl, an NH.sub.2 group, a COOH group;

R.sub.3 is hydrogen or a hydroxyl group; and

n is an integer between 0 and 10, with the proviso that n cannot be 0 if R.sub.3 is OH, and with the further proviso that:

R.sub.2 is different from the group having the formula ##STR57## wherein Q is a halogen atom, a nitro group or a trifluoromethyl group and T is methyl, ethyl or butyl when R.sub.1 is a methyl or ethyl group, R.sub.3 is hydrogen and n=0;

and the salts of said compounds with inorganic or organic bases when R.sub.1 =H.

2. A methylene-disphosphonic acid compound according to claim 1, having the formula (I) in which n=0 and ##STR58## R.sub.3 =H, and the salts of said compounds with inorganic or organic bases when R.sub.1 =H.

3. A methylene-disphosphonic acid compound according to claim 1, having the formula: ##STR59## or one of its salts with inorganic or organic bases.

4. Pharmaceutical compositions which contain in association with a pharmaceutically acceptable carrier an effective amount of a compound of formula (I): ##STR60## in which: R.sub.1 is hydrogen or a straight or branched lower alkyl group having from 1 to 4 carbon atoms

R.sub.2 is a phenyl group which is or substituted one or more times by halogen, a nitro group, a lower alkyl group, a lower alkoxy group, trifluoromethyl, an NH.sub.2 group, a COOH group;

R.sub.3 is hydrogen or a hydroxyl group; and

n is an integer between 0 and 10, with the proviso that n cannot be 0 if R.sub.3 is OH;

or of one of its salts with inorganic or organic bases when R.sub.1 =H.

5. A pharmaceutical composition according to claim 4, which contains from 10 to 500 mg of the compound of formula I as an active ingredient.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Farmers Insurance
Cipla
Medtronic
Mallinckrodt
AstraZeneca
Queensland Health
QuintilesIMS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot